Literature DB >> 16855855

Hierarchical clustering analysis of flexible GBR 12909 dialkyl piperazine and piperidine analogs.

Kathleen M Gilbert1, Carol A Venanzi.   

Abstract

Pharmacophore modeling of large, drug-like molecules, such as the dopamine reuptake inhibitor GBR 12909, is complicated by their flexibility. A comprehensive hierarchical clustering study of two GBR 12909 analogs was performed to identify representative conformers for input to three-dimensional quantitative structure-activity relationship studies of closely-related analogs. Two data sets of more than 700 conformers each produced by random search conformational analysis of a piperazine and a piperidine GBR 12909 analog were studied. Several clustering studies were carried out based on different feature sets that include the important pharmacophore elements. The distance maps, the plot of the effective number of clusters versus actual number of clusters, and the novel derived clustering statistic, percentage change in the effective number of clusters, were shown to be useful in determining the appropriate clustering level. Six clusters were chosen for each analog, each representing a different region of the torsional angle space that determines the relative orientation of the pharmacophore elements. Conformers of each cluster that are representative of these regions were identified and compared for each analog. This study illustrates the utility of using hierarchical clustering for the classification of conformers of highly flexible molecules in terms of the three-dimensional spatial orientation of key pharmacophore elements.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855855     DOI: 10.1007/s10822-006-9046-2

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  47 in total

1.  2D conformationally sampled pharmacophore: a ligand-based pharmacophore to differentiate delta opioid agonists from antagonists.

Authors:  Denzil Bernard; Andrew Coop; Alexander D MacKerell
Journal:  J Am Chem Soc       Date:  2003-03-12       Impact factor: 15.419

2.  Conformational energy penalties of protein-bound ligands.

Authors:  J Boström; P O Norrby; T Liljefors
Journal:  J Comput Aided Mol Des       Date:  1998-07       Impact factor: 3.686

3.  Highly selective chiral N-substituted 3alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues for the dopamine transporter: synthesis and comparative molecular field analysis.

Authors:  M J Robarge; G E Agoston; S Izenwasser; T Kopajtic; C George; J L Katz; A H Newman
Journal:  J Med Chem       Date:  2000-03-23       Impact factor: 7.446

4.  Heteroaromatic analogs of 1-[2-(diphenylmethoxy)ethyl]- and 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as high-affinity dopamine reuptake inhibitors.

Authors:  D Matecka; D Lewis; R B Rothman; C M Dersch; F H Wojnicki; J R Glowa; A C DeVries; A Pert; K C Rice
Journal:  J Med Chem       Date:  1997-02-28       Impact factor: 7.446

5.  2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.

Authors:  B T Hoffman; T Kopajtic; J L Katz; A H Newman
Journal:  J Med Chem       Date:  2000-11-02       Impact factor: 7.446

6.  Fundamental reaction mechanism for cocaine hydrolysis in human butyrylcholinesterase.

Authors:  Chang-Guo Zhan; Fang Zheng; Donald W Landry
Journal:  J Am Chem Soc       Date:  2003-03-05       Impact factor: 15.419

7.  Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.

Authors:  J Barnett-Norris; F Guarnieri; D P Hurst; P H Reggio
Journal:  J Med Chem       Date:  1998-11-19       Impact factor: 7.446

8.  Structure-activity relationship studies of novel 4-[2-[bis(4-fluorophenyl)methoxy]ethyl]-1-(3-phenylpropyl)piperidine analogs: synthesis and biological evaluation at the dopamine and serotonin transporter sites.

Authors:  A K Dutta; C Xu; M E Reith
Journal:  J Med Chem       Date:  1996-02-02       Impact factor: 7.446

9.  Synthesis, ligand binding, QSAR, and CoMFA study of 3 beta-(p-substituted phenyl)tropane-2 beta-carboxylic acid methyl esters.

Authors:  F I Carroll; Y G Gao; M A Rahman; P Abraham; K Parham; A H Lewin; J W Boja; M J Kuhar
Journal:  J Med Chem       Date:  1991-09       Impact factor: 7.446

10.  Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.

Authors:  Santosh S Kulkarni; Peter Grundt; Theresa Kopajtic; Jonathan L Katz; Amy Hauck Newman
Journal:  J Med Chem       Date:  2004-06-17       Impact factor: 7.446

View more
  4 in total

1.  Singular value decomposition analysis of the torsional angles of dopamine reuptake inhibitor GBR 12909 analogs: effect of force field and charges.

Authors:  Deepangi Pandit; Anna Fiorentino; Supreet Bindra; Carol A Venanzi
Journal:  J Mol Model       Date:  2010-09-14       Impact factor: 1.810

2.  Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.

Authors:  Denzil Bernard; Andrew Coop; Alexander D MacKerell
Journal:  J Med Chem       Date:  2007-03-17       Impact factor: 7.446

3.  DAT/SERT selectivity of flexible GBR 12909 analogs modeled using 3D-QSAR methods.

Authors:  Kathleen M Gilbert; Terrence L Boos; Christina M Dersch; Elisabeth Greiner; Arthur E Jacobson; David Lewis; Dorota Matecka; Thomas E Prisinzano; Ying Zhang; Richard B Rothman; Kenner C Rice; Carol A Venanzi
Journal:  Bioorg Med Chem       Date:  2006-10-01       Impact factor: 3.641

4.  Conformational analysis of piperazine and piperidine analogs of GBR 12909: stochastic approach to evaluating the effects of force fields and solvent.

Authors:  Deepangi Pandit; William Roosma; Milind Misra; Kathleen M Gilbert; William J Skawinski; Carol A Venanzi
Journal:  J Mol Model       Date:  2010-04-23       Impact factor: 1.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.